Skip to main content

Recall Issued for Antibiotic

May 24, 2018

Prescript Pharmaceuticals Inc. is recalling 2 lots of clindamycin capsules because of incorrect storage instructions on the product label, according to the May 23, 2018, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects:

  • 150-mg clindamycin capsules in 30-count M-Pak containers (NDC 00527-1382-01) from lot 0130126 (no expiration date available), and
  • 300-mg clindamycin capsules in 28-count M-Pak containers (NDC 00527-1383-01) from lot 0130132 (Exp. 3/31/19).

The capsules were manufactured by Lannett Company Inc., packaged by Prescript Pharmaceuticals, and distributed in California.

Prescript Pharmaceuticals voluntarily issued the recall April 24, 2018. The FDA designated it a Class II recall May 14, 2018. Using tablets recalled under a Class II designation could cause temporary or medically reversible adverse health consequences or a remote probability of serious harm, according to the FDA.

Available with a prescription, clindamycin is an antibiotic medication used to treat a variety of bacterial infections.

Jolynn Tumolo

For more Pharmacy Learning Network articles, visit the homepage

To learn about Pharmacy Learning Network Live meetings, click here

Back to Top